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In Brief
Many epithelial pathologies induce loss of apicobasal polarity. Epithelial intercellular adhesion molecule 1 (ICAM-1) mediates lymphocyte adhesion to hepatic epithelial cells. Reglero-Real et al. now show that polarized hepatocytes and bile duct epithelial cells confine ICAM-1 to their apical membrane domains, which are less accessible to circulating immune cells. Upon depolarization, apical ICAM-1 is exposed and increases lymphocyte binding. Epithelial apicobasal polarity thus helps the immune system to discriminate between normal and depolarized, dysfunctional hepatic cells exposing their adhesion machinery.
INTRODUCTION
Hepatocytes are polarized epithelial cells that delimit an apical lumen that forms channels for draining bile, the bile canaliculi (BCs), and a basolateral membrane that is exposed to the space of Disse and interacts with the sinusoids, extravasated leukocytes, and other parenchymal cells (Lee, 2012; Wang and Boyer, 2004) . BCs drain into bile ducts, which are formed by polarized epithelial cells called cholangiocytes (Lee, 2012) . A correct polarized architecture is necessary for hepatic epithelial cell function, and loss of hepatic apicobasal polarity is a hallmark of liver pathology. Hepatocytes injured after trauma, hepatoma cells, and hepatocytes infected with hepatitis B virus (HBV) or hepatitis C virus (HCV) lose their polarity (Benedicto et al., 2011; Mee et al., 2010; Shousha et al., 2004) . Reduced hepatocyte polarization has been found in biopsies of liver carcinomas and livers at different stages of cirrhosis or hepatitis infection (Shousha et al., 2004) .
Leukocyte infiltration into the liver is essential for immune surveillance, controls cancer and infections, and facilitates tissue regeneration. Aberrant leukocyte-hepatocyte interactions trigger liver failure in autoimmune diseases and rejection after transplantation, and exacerbate liver damage upon severe trauma. Hepatocyte death, injury, oncogenic transformation, and virus infection promote extravasation across the sinusoids of immune cells, which search for antigen presentation, damaged or transformed cells, cell debris, or microorganisms (Hiraoka, 2010; Holz et al., 2010; Kang et al., 2011) . Efficient leukocyte migration in the parenchyma involves various molecular cues, including secreted chemokines and cytokines, and haptotactic factors such as extracellular matrix components and adhesion receptors exposed on sinusoidal and parenchymal cell surfaces (Edwards et al., 2005; McGettrick et al., 2012) . The interaction between leukocyte b2 integrins and intercellular adhesion molecule 1 (ICAM-1) is of central importance in the epithelial inflammatory response (Chin and Parkos, 2007) . The molecular mechanisms that regulate leukocyte adhesion to hepatic epithelial cells have not yet been investigated in detail; however, a role for hepatic ICAM-1 as a counterreceptor of leukocyte integrins for neutrophils, T cells, and T cell hybridomas has been reported (Meijne et al., 1994; Morita et al., 1994; Nagendra et al., 1997 ).
Here we demonstrate that apicobasal polarity negatively regulates lymphocyte adhesion to hepatic cells through the confinement of ICAM-1 in their apical membrane domains, which are not accessible by immune cells. This confinement is observed both in vitro and in vivo and is regulated by the proinflammatory cytokine tumor necrosis factor alpha (TNF-a). Our results indicate that in dysfunctional hepatic parenchyma, leukocytes appear to discriminate between operative hepatocytes that segregate adhesion receptors onto BCs and depolarized and chronically inflamed adjacent hepatocytes that expose their adhesion machinery.
RESULTS

Loss of Apicobasal Polarity Increases Lymphocyte Adhesion to HepG2 Cells
To investigate the effect of the loss of hepatocellular polarity on T lymphocyte adhesion, we first took advantage of the hepatoma cell line HepG2, which retains the main polarity features of primary hepatocytes and is thus a prototypical model for investigating apicobasal polarity (Madrid et al., 2010; van IJzendoorn et al., 1997) . Depending on the cell passage, 40%-60% of HepG2 cells showed a polarized morphology, forming colonies containing spherical or tubular apical lumens between two or more cells (Figure 1A, left) . These lumens are sealed by cellcell junctions and are reminiscent of bona fide BCs (Madrid et al., 2010) . It has been reported that classical PKC activation with phorbol esters, such as phorbol-12 myristate-13 acetate (PMA), reduces HepG2 polarization, whereas analogs of cyclic AMP (cAMP), such as dibutyryl-cAMP (dcAMP), promote the formation of BCs (Fu et al., 2011; Zegers and Hoekstra, 1997) . We first analyzed the effect of PMA and dcAMP on HepG2 cell polarity and interaction with T lymphocytes. We addressed cell polarity by counting the number of BCs, as identified by double staining of F-actin and the glycosylphosphatidylinositol (GPI)-anchored protein CD59, which partially accumulates in the BCs ( Figure 1A ) or by double staining with the canalicular markers multidrug resistance-associated protein 2 (Mrp-2) and phosphorylated ezrin-radixin-moesin (ERM) proteins (Kikuchi et al., 2002;  Figure S1 ). PMA reduced the number of BCs by 70% ( Figure 1A ) and the percentage of polarized cells to 10%-20% of total HepG2 cells. In contrast, dcAMP increased them by 23% respect to untreated cells. Interestingly, after extensive washes, PMA-treated HepG2 cells increased T cell adhesion by 71%, whereas dcAMP-treated HepG2 cells decreased it by 22% ( Figure 1B ). Signaling pathways that regulate cell polarity are involved in the inflammatory response (Mashukova et al., 2011) and can induce the expression of adhesion receptors that interact with immune cells (Delpino et al., 2010) . To test whether the inverse correlation between apicobasal polarity and T cell adhesion could be attributed to the de novo synthesis of surface adhesion receptors, we performed depolarization assays in the presence of the inhibitor of protein biosynthesis cycloheximide (CHX). We observed no significant effect of CHX on polarity (not shown) or lymphocyte adhesion ( Figure 1B ) in either control or PMA-pretreated HepG2 cells, which indicates that this increase in T cell adhesion is independent of de novo receptor synthesis.
To rule out the possibility that PMA or dcAMP affect hepatic cell-leukocyte adhesion independently of the modulation of apicobasal polarity, we followed an alternative strategy and targeted the Cdc42-mediated signaling axis in HepG2 cells, which plays a central role in the generation of cell polarity. The Rho GTPase Cdc42 serves as a master regulator of cell polarity by controlling vesicular trafficking, cell-cell junctions, and signaling pathways that mediate cell polarization (Madrid et al., 2010; Martin-Belmonte et al., 2007) . Cdc42 knockdown with two small interfering RNA (siRNA) oligonucleotides reduced the number of BCs in HepG2 cells to 52% and 53% of those found in cells transfected with siRNA control (Figures 1C and 1D ). This reduction of polarity correlated with an increased adhesion of human primary T lymphocytes to hepatic cells by 35% and 27%, respectively ( Figure 1E ). Cdc42 regulates the partitioning-defective (PAR) polarity complex, which comprises the proteins PAR3, PAR6, and atypical protein kinase C (aPKC), and promotes the establishment of the apical-basal membrane border (MartinBelmonte and Mostov, 2008) . aPKC can be inhibited with a pseudosubstrate peptide (PS-aPKC) that impairs apical lumen morphogenesis (Martin-Belmonte et al., 2007) . Similarly to Cdc42 knockdown, PS-aPKC reduced the number of BCs by almost 50% ( Figure 1F ) and increased lymphocyte adhesion by 62% ( Figure 1G ). Finally, in the absence of depolarizing treatment, we found that T lymphocytes preferentially adhered to the subpopulation of unpolarized hepatic cells ( Figure 1H ). In summary, by modulating the polarity of HepG2 cells using four different approaches, we identified an inverse correlation between their apicobasal architecture and their ability to interact with T lymphocytes.
ICAM-1 Is Confined in the BCs of Polarized Hepatocytes and Exposed to Lymphocytes upon Loss of Polarity
In the liver parenchyma, infiltrated leukocytes preferentially establish contacts with the basolateral membranes of polarized hepatic cells, which are exposed to the sinusoids (Warren et al., 2006) . The b2 integrin counterreceptor ICAM-1 mediates leukocyte adhesion to endothelial and epithelial cells (Meijne et al., 1994; Reglero-Real et al., 2012) . Confocal analysis of polarized HepG2 cells and human primary hepatocytes revealed low levels of ICAM-1 staining at basolateral membrane domains. The receptor was mostly confined to the BCs, where it colocalized with F-actin-rich microvilli (Figures 2A and 2B ) and was surrounded by cell-to-cell junctional markers such as desmosomal desmoglein-2 (Dsg-2) ( Figure S2A ). The distribution of ICAM-1 was comparable to that of other canalicular markers, such as radixin, Mrp-2, and active phosphorylated ERM (p-ERM) proteins (ezrin [T567], radixin [T568], and moesin [T558] ( Figure 2B ; Kikuchi et al., 2002) . Upon induction of HepG2 cell depolarization, canalicular ICAM-1 was dispersed in discrete domains distributed over the entire cell area ( Figure 2C ). These structures were positive for F-actin and resembled the staining pattern of ICAM-1-rich microvilli found in nonpolarized epithelial and endothelial cells (Figure 2C, inset; Millá n et al., 2006) . Phosphorylation at a specific threonine residue close to the C terminus is required to promote the open conformation of active ERMs (Ivetic and Ridley, 2004) , which regulate microvilli by connecting F-actin to plasma membrane proteins. Untreated, polarized HepG2 cells accumulated active p-ERM proteins in the apical membranes ( Figure 2D ), as occurs in primary hepatocytes ( Figure 2B ; Kikuchi et al., 2002) . Upon collapse of the BCs, active ERMs were localized in sparse, discrete domains on the plasma membrane-a redistribution pattern that was very similar to that of microvilli and ICAM-1 (Figures 2C and 2D) . Immunostaining of ICAM-1 prior to permeabilization of depolarized HepG2 cells stably expressing ICAM-1-GFP showed that ICAM-1 domains were exposed on the cell surface ( Figure 2E ). Scanning electron microscopy of HepG2 cells revealed the appearance of long surface filaments resembling canalicular microvilli upon induction of depolarization ( Figure 2F ). In order to analyze quantitatively whether plasma membrane ICAM-1 is more exposed to the extracellular milieu upon depolarization, we labeled surface proteins of untreated or depolarized HepG2 cells in the cold with membrane-impermeable sulfo-NHS-biotin, which could not reach the BCs. Biotinylated (and thus exposed) ICAM-1 was detected by pull-down assays with neutravidin-conjugated agarose ( Figure 2G ). Although not all of the untreated HepG2 cells had a polarized phenotype before the induction of depolarization, the exposed-to-total protein ratio clearly showed that ICAM-1 and p-ERM proteins, which were associated with biotinylated plasma membrane receptors, were more accessible from the extracellular milieu in response to the depolarizing (legend continued on next page) challenge. Cdc42 knockdown and incubation with PS-aPKC also increased ICAM-1 dispersion ( Figure S2B ) and biotinylation ( Figure S2C ). Altogether, these findings indicate that loss of polarity exposes actin-and ERM-rich canalicular microvilli containing ICAM-1 on cell surfaces. Indeed, time-lapse analysis of T cells migrating on depolarized HepG2 stably expressing ICAM-1-GFP showed local receptor redistribution into microvilli-like protrusions surrounding the adhered lymphocyte (Figure 3A , arrows; Movie S1). Extensive confocal analysis followed by 3D image reconstruction also revealed endogenous ICAM-1-and F-actin-rich membrane projections around lymphocytes adhered to unpolarized hepatic cells ( Figures 3B-3D ). This membrane reorganization resembles the endothelial docking structures that mediate leukocyte transendothelial migration (TEM) (Barreiro et al., 2002; van Buul et al., 2007 ). Finally, we tested whether ICAM-1 mediates lymphocyte adhesion in depolarized HepG2 cells. HepG2 cells were transfected with control siRNA or two different siRNA oligonucleotides that efficiently knock down ICAM-1 (siICAM-1) ( Figure 3E ). Cells were then depolarized with PMA+CHX and T cell adhesion assays were performed. ICAM-1-depleted hepatic cells showed a significant reduction in T cell adhesion, which was $50% of the increase in adhesion observed upon induction of depolarization (Figures 3F and 1B) . As a control, transfection of siICAM-1(2), which targets the 5 0 UTR of ICAM-1 mRNA, did not reduce ICAM-1-GFP expression ( Figure 3E ) and thus had no effect on lymphocyte adhesion to HepG2 cells expressing exogenous ICAM-1 ( Figure 3F ). These results imply that the effect of ICAM-1 siRNA specifically results from a reduction in endogenous ICAM-1 expression. Consistent with these findings, blocking antibodies against ICAM-1 or LFA-1 also reduced lymphocyte adhesion to HepG2 cells ( Figure 3G ).
Polarized Hepatic Cells Prevent ICAM-1 Exposure to Basolateral Membranes by Redirecting Basolateral ICAM-1 to BCs
To investigate the mechanisms whereby polarized cells prevent ICAM-1 localization at basolateral domains that face circulating immune cells, we first studied the dynamics of polarized ICAM-1. ICAM-1 fused from its cytoplasmic C terminus to a photoactivatable GFP (paGFP) protein was generated and stably expressed in HepG2 cells (Patterson and Lippincott-Schwartz, 2002) . Like endogenous ICAM-1 ( Figure 2A ) and ICAM-1-GFP (see Figure 5B ), ICAM-1-paGFP was confined to the canalicular membrane of polarized HepG2 cells (not shown). To identify polarized cell colonies, actin-cherry was expressed in ICAM-1-paGFP-HepG2 cells. ICAM-1-paGFP was first photoactivated in the BCs and examined by time-lapse confocal microscopy (Figures 4A and 4B; Movie S2) . No significant decrease in fluorescence was detected during the first 100 min poststimulation. The increase in fluorescence in the adjacent basolateral regions was also negligible, implying that ICAM-1-paGFP is remarkably confined in BCs. Intracanalicular diffusion could not be adequately analyzed due to the small size of these structures. Polarized targeting to the canalicular surface of newly synthesized proteins can take place by direct and indirect transport routes. In the direct route, proteins from the Golgi are delivered directly to the apical membrane. However, some apical proteins, including a number of single-span transmembrane proteins, can follow an indirect pathway and be segregated in the Golgi into different carriers that transport them first to the basolateral membrane and then to their final apical destination by transcytosis (Bastaki et al., 2002) . Similar to what was observed for endogenous ICAM-1, only a minor fraction of ICAM-1-paGFP was localized at the basolateral membrane domains. Importantly, this fraction could be photoactivated, although it yielded much less intense fluorescence ( Figure 4C ; Movie S3). Compared with the slow apical-to-basolateral diffusion rate, ICAM-1-paGFP completely diffused out from basolaterally photoactivated areas within the first 10 min following photoactivation (Figures 4C and  4D ; Movie S3). Long-term analysis of basolaterally photoactivated ICAM-1-paGFP revealed that the receptor first diffused within basolateral membranes and then accumulated progressively in the BCs. Simultaneously, basolateral fluorescence decreased, indicating the existence of a basolateral-to-apical trafficking of ICAM-1 (Figures 4E and 4F ; Movie S4). Therefore, this population of basolaterally delivered ICAM-1 undergoes subsequent redirection to the apical canaliculus in polarized hepatic cells, where it can remain stable for at least 100 min. Consistent with these results, although only a minor fraction of ICAM-1 was localized in the basolateral membrane, basolateral ICAM-1 (not shown) and ICAM-1-GFP ( Figure 4G ) could be clearly labeled in live, unpermeabilized cells with a specific antibody. At 90 min after this immunolabeling, the antibody partially accumulated in BCs, indicating a basolateral-to-apical transport of labeled ICAM-1. Hence, these results indicate that the (B) Primary human hepatocytes were grown for 3 days in collagen sandwiches and then fixed and stained for ICAM-1 and F-actin (top left). The bottom left shows the fluorescence intensity profile along the white arrow crossing a BC. Primary human hepatocytes were grown for 5-6 days in collagen sandwiches, fixed, and stained for ICAM-1, radixin, Mrp-2, or p-ERM proteins (right). (C and D) HepG2 cells grown for 72 hr were depolarized with PMA+CHX for the indicated times. Cell were fixed and stained for F-actin and ICAM-1 (C) or for p-ERM proteins (D). (E) HepG2 cells stably expressing ICAM-1GFP were depolarized as in (C) for 2 hr, incubated in the cold with anti-ICAM-1 antibody, fixed, and analyzed by confocal microscopy. (F) Scanning electron microscopy analysis of polarized and depolarized HepG2 cells. The enlarged area shows microvilli-like protrusions appearing in cells that are losing their polarity. (G) HepG2 cells undergoing depolarization by PMA+CHX treatment at different times were incubated with sulfo-NHS-biotin and lysed. Surface-biotinylated proteins (Exposed) were isolated by pull-down assay with neutravidin-agarose. (H) The ratio of extracellularly exposed-to-total ICAM-1 is expressed as a percentage of the ratio in control cells. Surface ICAM-1 levels increased between 2-and 3-fold upon loss of polarity and subsequently decayed at later times due to the constitutive internalization of surface proteins in CHX-treated cells. *p = 0.034, n = 4. Scale bars represent 10 mm. See also Figure S2 .
substantive differences between basolateral-to-apical and apical-to-basolateral trafficking of surface ICAM-1 prevent receptor localization at basolateral membranes, which in vivo are exposed in the liver to the space of Disse, vasculature, and immune cells.
ICAM-1 Associates with ERM Proteins at the Plasma Membrane through Its Cytoplasmic Tail, which Is Required for ICAM-1 Apical Localization
We next addressed which receptor domain is responsible for ICAM-1 confinement in BCs. Basolateral localization of ICAM-1-Dct-GFP, which lacks the receptor cytoplasmic tail, was increased compared with the ICAM-1-GFP distribution, whereas GFP fused to ICAM-1 lacking the extracellular domain (GFP-ICAM-1-Dext) was sufficient to target GFP to BCs (Figures 5A-5D ). These results indicate that apical segregation of ICAM-1 is partially dependent on its cytoplasmic segment. To gain insight into the role of the ICAM-1 cytoplasmic segment in ICAM-1 polarity, we stably expressed ICAM-1-Dct-paGFP in hepatic cells and analyzed its dynamics after photoactivation. Absence of the cytoplasmic segment did not reduce the canalicular confinement of ICAM-1-Dct-paGFP (Figures 5E and S3A ; Movie S5). In contrast, basolateral-to-apical trafficking was clearly reduced compared with that of ICAM-1-paGFP (Figures 5F, S3B, and S3C; Movie S6), suggesting that the ICAM-1 cytoplasmic segment regulates the basolateral-to-apical traffic of ICAM-1. Adhesion receptors from the immunoglobulin superfamily, such as ICAM-1 and VCAM-1, can interact from their cytoplasmic tail with proteins that connect them to the subcortical actin cytoskeleton, such as filamin, a-actinin, and the ERM proteins (Barreiro et al., 2002; Carpé n et al., 1992; Kanters et al., 2008; Oh et al., 2007) . Radixin and ezrin, which are the most abundant ERM proteins in hepatocytes and hepatoma cells, are essential for maintaining the BC structure and determine the apical localization of canalicular membrane proteins such as Mrp-2 (Gilbert et al., 2012; Kikuchi et al., 2002) . We found that ICAM-1 colocalized with radixin and ezrin in polarized and depolarized cells ( Figure 5G ). Furthermore, antibody-mediated crosslinking of ICAM-1 induced radixin-YFP and ezrin-GFP coclustering at the plasma membrane in HepG2 cells ( Figure 5H ). ICAM-1 crosslinking in primary human hepatocytes induced a significant coclustering of active ERM proteins ( Figure S3D ). This coclustering depended on the receptor cytoplasmic segment, since ICAM-1 Dct-GFP clusters accumulated significantly fewer p-ERM proteins at the plasma membrane of HepG2 cells compared with ICAM-1-GFP clusters ( Figure 5I ). In accordance with this, pulldown assays revealed that the ICAM-1 cytoplasmic tail associates with phosphorylated radixin and ezrin ( Figure 5J ). The substitution of three lysine residues close to the transmembrane segment of the receptor by leucine was sufficient to abrogate the binding of hepatic ERM proteins to the receptor cytoplasmic segment ( Figures 5J and 5K ) and induced a partial depolarization of ICAM-1 ( Figure 5L ). This supports previous reports describing the requirement of a short domain that contains basic amino acids for the interaction between the ICAM-1 tail and actin connectors in other cell types (Carpé n et al., 1992; Oh et al., 2007) . ICAM-1-K>L-GFP was not as depolarized as ICAM-1-Dct-GFP, which suggests that additional interactions of ICAM-1 tail with other cytoplasmic proteins contribute to the receptor polarity. Collectively, these results indicate that in hepatic cells, ICAM-1 is also associated with active ERM and F-actin in microvilli, a machinery that mediates leukocyte adhesion when exposed to leukocytes (Reglero-Real et al., 2012) and also plays an important role in the maintenance of apicobasal polarity (Kikuchi et al., 2002; Wang et al., 2006) .
Long-Term TNF-a Stimulation Activates ERM Proteins at Basolateral Domains and Increases ICAM-1 Basolateral Exposure ICAM-1 expression, ERM protein activation, and leukocyte adhesion are induced by the cytokine TNF-a (Aranda et al., 2013; Koss et al., 2006) , which is fundamental to long-term liver inflammatory responses. We investigated the effect of long-term stimulation by TNF-a on hepatocellular polarity and ICAM-1 expression and polarization. HepG2 cells were stimulated at different times and the distribution of ICAM-1 was analyzed. In conjunction with a clear effect on ICAM-1 expression, immunofluorescence and surface biotinylation assays revealed that TNF-a significantly increased ICAM-1 and ICAM-1-GFP exposure to the extracellular milieu ( Figures 6A and 6B) . Importantly, 24 hr of TNF-a stimulation did not change the number of BCs in HepG2 cultures ( Figure 6C ) or the distribution of the cell-to-cell junctional marker ZO-1 (Figure S4A ), which suggests that the increase of ICAM-1 basolateral localization is not a consequence of TNF-a-mediated loss of apicobasal polarity. The analysis of TNF-a-induced ICAM-1 depolarization in the presence of CHX revealed that de novo synthesis of ICAM-1 is required for its basolateral localization ( Figure S4B ), suggesting that newly synthesized ICAM-1 reaches the basolateral domains first. Interestingly, TNF-a had no effect on the apical confinement of ICAM-1 ( Figure S4C ; Movie S7), but significantly reduced the basolateral-to-apical trafficking of the receptor (Figures 6D and S4D ).
TNF-a induced ERM phosphorylation in membrane protrusions at the basolateral membrane, which resembled surface microvilli ( Figure 6E ). An overall increase in ERM phosphorylation was also detected by western blot analysis, which showed that this increment occurred before the increase in ICAM-1 (Figure 6F) . ICAM-1 knockdown had no effect on ERM phosphorylation (not shown), ruling out a role for the receptor itself in ERM activation. For correct function and localization, ERM proteins must cycle between their active and inactive conformations (Viswanatha et al., 2012) . A constitutively active ERM mutant, ezrin T567D GFP (ezrin-TD-GFP), was mislocalized to the basolateral membrane. The expression of ezrin-TD-GFP was sufficient to induce the basolateral accumulation of ICAM-1 in HepG2 cells ( Figure 6G ) and to reduce basolateral-to-apical trafficking of ICAM-1 in cells with morphologically intact BCs ( Figures 6H  and S4E ), similar to the reduction observed upon long-term TNF-stimulation ( Figures 6D and S4D) . Expression of GFP alone had no effect on ICAM-1 polarization ( Figure S4F ). Together, these data indicate that basolateral ERM activation in response to long-term TNF-a activation can contribute to basolateral exposure of ICAM-1 without affecting the integrity of BCs in hepatic cells. The basolateral increase of ICAM-1 occurs by the delivery of newly synthesized ICAM-1 to the basolateral membrane and the subsequent slowdown of its basolateral-to-apical transport. ERM protein loss-of-function experiments were shown to affect overall hepatic cell polarization (Suda et al., 2011; Wang et al., 2006) , which prevented these strategies from being adopted for further studies of ICAM-1 distribution.
Polarized Hepatocytes and Bile Duct Epithelial Cells Can
Confine ICAM-1 to the Apical Membrane Domains Finally, we studied ICAM-1 distribution in human tissue samples from healthy donors and from patients with short-term or chronic inflammatory liver dysfunction (Tables S1 and S2 ). First, we analyzed samples from rejected human liver allografts that were collected after a relatively short inflammatory response by the host, which preserved their hepatocyte integrity in many tissue areas. ICAM-1 was detected in the endothelial cells lining the sinusoids, but also in hepatocytes that were concentrated in BCs in areas that were apparently undamaged and showed no leukocyte infiltration ( Figure S5A , images R1-R3, arrows, right insets). ICAM-1 expression was also significant in the sinusoids from healthy control donors, but it was weak or absent in most of the hepatocytes ( Figure S5A , image Ct, arrows). Epithelial cells from some bile ducts also expressed ICAM-1, always polarized in the apical surface ( Figure S5B ). Hepatocytes expressing polarized ICAM-1 were often found close to portal areas, whereas small foci of parenchymal cells expressing depolarized ICAM-1 were occasionally found dispersed in the parenchyma ( Figure S5C ). Given that periportal hepatocytes are in proximity to T cell infiltrates, ICAM-1 polarization may constitute a protective mechanism for healthy hepatocytes that potentially can be exposed to immune cells. In contrast, in the parenchyma from livers in advanced stages of HCV and HBV infection, we found ICAM-1 confinement in BCs in some areas, but also a remarkable loss of ICAM-1 polarization in others. Immunohistochemical analysis of consecutive tissue sections, followed by accurate pattern recognition based on duct, sinusoidal, and canalicular (Figures 7A and 7B) . Similar to what was observed in sections from allograft rejections, cholangiocytes from some bile ducts strongly expressed and polarized ICAM-1 in luminal membrane domains ( Figure 7B ). As previously reported (Shousha et al., 2004) , hepatocytes in many tissue regions lost apicobasal polarity and as a consequence also displayed an unpolarized ICAM-1 distribution ( Figure 7C ). However, a significant number of hepatocytes that did not apparently polarize ICAM-1 still concentrated CD10 into canalicular-like structures (Figure 7D) , suggesting the existence in vivo of mechanisms that induce ICAM-1 basolateral exposure in polarized hepatocytes, such as strong stimulation by inflammatory cytokines. Taken together, these data reveal that hepatic parenchymal cells with an intact apicobasal architecture can segregate the ICAM-1 receptor onto apical surfaces, which may not be accessible from sinusoidal or perisinusoidal cells such as infiltrated leukocytes. ICAM-1 loses its apical polarity in chronic liver diseases that affect the hepatocyte architecture and cause persistent inflammatory stress.
DISCUSSION
Immunosurveillance plays a central role in clearing and receiving information from dysfunctional epithelial cells in the parenchyma (Chin and Parkos, 2007; Kang et al., 2011) . However, the molecular mechanisms that regulate the communication between immune cells and the hepatic epithelium are still poorly understood. ICAM-1 contributes to leukocyte adhesion to primary, nonpolarized hepatocytes (Meijne et al., 1994; Morita et al., 1994) and to hepatocyte-derived cell lines stimulated with a proinflammatory cytokine cocktail (Nagendra et al., 1997) . Here we show that unstimulated cultured HepG2 and primary hepatocytes, as well as hepatocytes from undamaged hepatic parenchymal regions, remarkably segregate ICAM-1 into apical plasma membranes. Hepatic cells must lose polarity or be exposed to long-term inflammatory stimulation in order to make this receptor accessible to immune cells. Hence, the polarized architecture of hepatic cells emerges as a mechanism for modulating the intensity of the inflammatory response in the liver. Recent reports indicated that hepatocytes play a more important role in leukocyte adhesion than expected, even before immune cells egress from the hepatic microcirculatory system, since ICAM-1 on hepatocyte microvilli directly contact leukocytes circulating by the sinusoids through endothelial fenestrae (Warren et al., 2006) . In this way, ICAM-1 participates in antigen presentation to circulating, sinusoidal lymphocytes, which may be a determinant in the pathogenesis of viral hepatitis or in liver-induced immune tolerance.
Thus, hepatic ICAM-1 polarization may be relevant for both innate and adaptive immune responses in the liver.
In hepatic cells exposing ICAM-1 upon depolarization, the receptor is reorganized into microvilli-derived structures that embrace interacting lymphocytes. These structures are similar to the docking complexes formed between ICAM-1 and ERM proteins in endothelial cells, which are required for an efficient leukocyte TEM (Barreiro et al., 2002; Reglero-Real et al., 2012) . However, in hepatocytes, active ERM proteins play roles other than those described for leukocyte extravasation. The luminal domain of hepatocytes delimits the BC, a channel in which microvilli are abundant and the hepatocytes drain bile. Subcortical filamentous actin and ERM proteins accumulate in BCs and regulate cell polarity, canalicular microvilli, and canalicular membrane localization of proteins such as the detoxifying transporter Mrp-2 (Kikuchi et al., 2002; Wang et al., 2006) . Our data suggest that the ERM protein's interaction with hepatic ICAM-1 also plays a role in its polarized localization, which in turn determines the lymphocyte-hepatic cell interaction. We propose that the dual role of the protein machinery formed by ERM proteins and microvillar actin bundles (i.e., regulating either lymphocyte adhesion or apicobasal polarity) underlies the inverse relation found between these two processes in hepatic cells. When confined in canalicular microvilli, the machinery regulates hepatocellular polarity and drainage functions while it also contributes to attenuate the inflammatory response by confining adhesion receptors. Upon cell damage or persistent inflammation with cytokines such as TNF-a, the machinery is exposed and plays haptotactic roles comparable to those observed in endothelial cells.
Using different experimental strategies, we have also demonstrated that the basolateral-to-apical traffic of ICAM-1 regulates its polarity. The basolateral activation of ERM proteins by TNF-a delays basolateral-to-apical trafficking of ICAM-1, probably by retaining the receptor associated with basolateral actin structures (Oh et al., 2007) . Further studies on the mechanisms that regulate the activation of ERM proteins in different membrane domains in hepatic cells may thus facilitate the development of new therapeutic approaches to control the distribution of adhesion receptors and liver function during inflammation.
Collectively, our data obtained in vitro indicate that in addition to chemotactic gradients, hepatocellular polarity and the extension of the inflammatory response may provide haptotactic cues that infiltrated leukocytes use to discriminate dysfunctional hepatocytes from polarized, still-operative hepatocytes in damaged parenchyma. Of note, the ICAM-1 distribution observed in human tissue samples from livers with acute or long-term inflammatory dysfunction is consistent with our in vitro observations. Liver allograft rejections and livers chronically infected with fluorescence decreased from the basolateral regions and accumulated in the canalicular areas. The asterisk marks the background fluorescence emission detected prior to PA. (F) Quantification of fluorescence in basolateral and canalicular (BC) regions adjacent to photoactivated areas after background subtraction (n = 17 cells). (G) Basolateral ICAM-1 was labeled with anti-ICAM-1 antibody in polarized HepG2 cells stably expressing ICAM-1-GFP. At the indicated times, cells were fixed, permeabilized, and stained with TRITC-conjugated secondary antibody. Basolaterally labeled ICAM-1 receptor was partially found in BCs 90 min after antibody incubation (arrowheads). Right graph: quantification of the percentage of BCs that were positive for basolateral ICAM-1. **p = 0.0002, n = 4. Bars show the mean + SEM. Scale bars represent 10 mm. See also Figure S3 and Movies S2, S3, and S4.
(legend on next page)
HBV and HCV accumulated ICAM-1 in BCs in areas that preserved hepatocyte integrity. However, the hepatitis virus-infected livers clearly contained extensive parenchymal regions that lost hepatic apicobasal polarity, as revealed by staining of the canalicular marker CD10. They also had areas in which ICAM-1 had an unpolarized distribution but CD10 was still concentrated in canalicular-like structures, which is consistent with the existence of a persistent inflammatory response that promotes receptor basolateral accumulation in correctly polarized hepatocytes. Several inflammatory and stress stimuli contribute to ICAM-1 expression (Hubbard and Rothlein, 2000; Morita et al., 1994; Zhu et al., 2005) . Elucidating which stimulus regulates ICAM-1 polarization in hepatic cells in each pathological scenario is a long-term task that may provide a new perspective on the control of liver inflammatory diseases.
Our data are in agreement with those of a previous study of HBV-infected livers, in which parenchyma with mild HBV infection accumulated ICAM-1 in BCs, whereas parenchyma with high levels of LFA-1-positive lymphocyte infiltration and an exacerbated inflammatory response displayed a nonpolarized distribution of hepatocyte ICAM-1 (Doi et al., 1994) . Although no analysis of hepatocyte polarity was carried out in that particular report, other researchers have shown that HCV and HBV liver infections reduce hepatocyte polarity and contribute to the development of a hepatocellular-transformed phenotype (Akkari et al., 2012; Kew, 2011; Wilson et al., 2012) . Considering all these data together, we envisage that ICAM-1 basolateral exposure may help immune cells to identify hepatocytes in advanced stages of virus infection.
Mechanisms of apicobasal polarity are preserved in different epithelia, where the accessibility of immune cells to the lumens and internal cavities may be reduced relative to that in parenchymal spaces (Weisz and Rodriguez-Boulan, 2009 ). Therefore, polarization of epithelial receptors involved in adhesion and activation of immune cells may be a general mechanism to prevent exacerbation of the immune response that is not restricted to hepatic tissues. Indeed, an apical distribution of ICAM-1 has also been reported in human intestinal epithelia, in which this receptor mediates apical-to-basolateral leukocyte transmigration (Parkos et al., 1996) . Since loss of polarity is a general feature of epithelial cell dysfunction, we propose that the differential exposure of adhesion receptors that occurs as a consequence is an immune checkpoint for maintaining epithelial tissues free of damaged or transformed cells.
EXPERIMENTAL PROCEDURES Cells
Human hepatoma HepG2 cells were grown in high-glucose Dulbecco's modified Eagle's medium supplemented with 5% fetal bovine serum (Sigma). For stable expression of exogenous proteins, transfected cells were selected by treatment with 0.5 mg/ml G-418 sulfate for at least 4 weeks after transfection. Positive cell clones were maintained in drug-free medium. After several passages in this medium, >90% of cells retained expression of the exogenous product. Primary human hepatocytes were grown in collagen sandwiches with HCM medium (Lonza) for 5 days to induce polarization as previously described (Tolosa et al., 2011) . T lymphoblasts were prepared from isolated human peripheral blood mononuclear cells (PBMCs). Nonadherent PBMCs were stimulated with 0.5% phytohemagglutinin for 48 hr and maintained in interleukin-2 as previously described (Millá n et al., 2006) . T lymphoblasts were used in experiments after they were cultured for 7-12 days.
Modulation of HepG2 Polarity
In addition to Cdc42 siRNA transfection, HepG2 cell polarity was reduced by treatment with 100 nM PMA for up to 4 hr or with 40 mg/ml PS-aPKC for 18 hr. Polarity was increased by treatment with 100 mM dcAMP for 2 hr as previously described . Morphological analyses and BC quantitation were performed by staining for F-actin and CD59 in fixed HepG2 cells or primary hepatocytes. See also Figure S4 and Movie S7. See also Figure S5 .
Alternatively, adhesion experiments were also assayed using a confocal microscope to count calcein-or CMTMR-labeled T cells that adhered to HepG2 cell colonies. T cell adhesion was blocked by incubation of HepG2 cells with 10 mg/ml of mouse anti-ICAM-1 antibody or T cells with 15 mg/ml of mouse anti-CD11/CD18 (LFA-1) antibody 30 min before adhesion assays were conducted.
Labeling of Exposed Surface Receptors
HepG2 cells were subjected to various treatments to modulate polarity, rinsed with PBS Ca 2+ /Mg ++ , and incubated for 20 min with 250 mg/ml of sulfo-NHS-biotin.
The cells were washed and traces of unbound biotin were blocked by incubation for 20 min with Dulbecco's modified Eagle's medium plus 10% fetal calf serum. Labeled HepG2 cells were then lysed with 1% TX-100 in TNE containing protease and phosphatase inhibitors, and neutravidinagarose pull-down was performed. All of these procedures were performed at 4 C.
Photoactivation and Time-Lapse Confocal Microscopy
HepG2 cells stably expressing photoactivatable ICAM-1-paGFP or ICAM-1-Dct-paGFP were seeded on a 35-mm glass-bottom culture dish and cultured for 2 days. Imaging was performed with a 633 water immersion objective lens (Plan-Apochromat; NA 1.0) on an inverted microscope (AxioObserver) equipped with a confocal scanning system (LSM710; Zeiss). Cells were imaged in phenol-red-free HEPES 20 mM Hank's balanced salt solution medium in a heated chamber at 37 C. A 405 nm laser was used to photoconvert ICAM-1-paGFP within the defined area of interest. For short videos (up to 10 min total duration) photoactivation was performed using a single pulse at 40% laser power, followed by time series imaging at 3 s per frame. For videos up to 120 min, the basolateral or apical domain was photoactivated using several pulses at 40% laser power or one single-pulse at 20% laser power, respectively, followed by two to three frames at maximum scan speed, and then 1-2 hr at 10 min per frame. Two images were acquired before photoconversion and their average intensity was taken as background and subtracted from the fluorescence intensity obtained after photoactivation, and then normalized to the intensity obtained in the first image recorded after photoconversion. Images were analyzed using ZEN 2010 (Carl Zeiss) and ImageJ (NIH) software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, five figures, two tables, and seven movies and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.2014.08.007.
